An Audit of Influenza Vaccination Status in Adults with Inflammatory Bowel Disease
BACKGROUND Several guidelines recommend influenza vaccination for high-risk patients, including those on immune-suppressing medications (IS).
Saved in:
Main Authors: | Neeraj Narula, Amit S Dhillon, Usha Chauhan, John K Marshall |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2012/158362 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Should My Patient with Inflammatory Bowel Disease on Immunosuppressive Therapy be Vaccinated against Influenza Virus?
by: Neeraj Narula, et al.
Published: (2010-01-01) -
Exercise and Inflammatory Bowel Disease
by: Neeraj Narula, et al.
Published: (2008-01-01) -
Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study
by: Abhishek Abhishek, et al.
Published: (2024-05-01) -
Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)
by: Po-Han Huang, et al.
Published: (2025-12-01) -
Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives
by: Arash Assadsangabi, et al.
Published: (2019-01-01)